AUTOBAHN
Autobahn Therapeutics, Inc.
Mark For: AUTOBAHN® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90009439 |
| Registration Number | 6866931 |
| Mark Literal Elements | AUTOBAHN |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark |
| Current Location | NEW APPLICATION PROCESSING 2020-06-22 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Jared M. Barrett |
| Attorney Docket Number | 600098.202 |
Timeline
| 2020-06-18 | Application Filed |
| 2020-06-22 | Location: NEW APPLICATION PROCESSING |
| 2020-06-22 | Status: Live/Pending |
| 2020-06-22 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
| 2020-06-22 | Transaction Date |
| 2022-10-04 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Autobahn Therapeutics, Inc. |
| Address | Suite 370 9880 Campus Point Drive San Diego, CALIFORNIA UNITED STATES 92121 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | MULTI | 2020-06-18 |
 Drawing | JPEG | 2020-06-18 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for treating central nervous system (CNS) disorders; therapeutic agents for treating central nervous system (CNS) disorders; thyromimetic pharmaceutical preparations for treating central nervous system (CNS) disorders; thyromimetic therapeutic agents for treating central nervous system (CNS) disorders |
| GS0051 | Pharmaceutical preparations for treating central nervous system (CNS) disorders; therapeutic agents for treating central nervous system (CNS) disorders; thyromimetic pharmaceutical preparations for treating central nervous system (CNS) disorders; thyromimetic therapeutic agents for treating central nervous system (CNS) disorders |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-06-22 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 